Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Dr. Reddy's Laboratories Limited (NSE: DRREDDY), ISIN INE089A01031 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
DRREDDY last traded at ₹1381.00 (+0.58%), with a 52-week range of ₹1101.00 to ₹1414.90 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 26.63%, FIIs 20.30%, DIIs 31.87%, mutual funds 14.14%.
EquiSense Score (ECS): 49/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.